相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey
Davide Cao et al.
EUROPEAN HEART JOURNAL (2021)
Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial
Mariusz Tomaniak et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Ticagrelor With or Without Aspirin After PCI The TWILIGHT Platelet Substudy
Usman Baber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Monotherapy with a P2Y 12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis
Mauro Chiarito et al.
LANCET (2020)
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome The TICO Randomized Clinical Trial
Byeong-Keuk Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Oxidative stress in chronic kidney disease
Kristien Daenen et al.
PEDIATRIC NEPHROLOGY (2019)
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention The SMART-CHOICE Randomized Clinical Trial
Joo-Yong Hahn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI The STOPDAPT-2 Randomized Clinical Trial
Hirotoshi Watanabe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
R. Mehran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study
G. Ocak et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx et al.
LANCET (2018)
P2Y12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes: Review of the Current Evidence
Laurent Bonello et al.
CIRCULATION (2018)
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
Francesco Costa et al.
LANCET (2017)
Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease An Analysis of 3 Community-Based Cohort Studies
Nisha Bansal et al.
JAMA CARDIOLOGY (2017)
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study
Usman Baber et al.
AMERICAN HEART JOURNAL (2016)
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents Risk Scores From PARIS
Usman Baber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The Risk of Major Hemorrhage with CKD
Amber O. Molnar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease Results From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Registry
Usman Baber et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2015)
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention
Philippe Genereux et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
Kunihiro Matsushita et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Haemostasis in chronic kidney disease
Jens Lutz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
The Impact of Renal Impairment on Long-Term Safety and Effectiveness of Drug-Eluting Stents
Giulio G. Stefanini et al.
PLOS ONE (2014)
Antithrombotic Therapy in Patients With Chronic Kidney Disease
Davide Capodanno et al.
CIRCULATION (2012)
Third Universal Definition of Myocardial Infarction
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Coronary Plaque Composition, Morphology, and Outcomes in Patients With and Without Chronic Kidney Disease Presenting With Acute Coronary Syndromes
Usman Baber et al.
JACC-CARDIOVASCULAR IMAGING (2012)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel
Olivier Morel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation
P. C. J. Armstrong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Stefan James et al.
CIRCULATION (2010)
Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)
Arijit Dasgupta et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
Roxana Mehran et al.
EUROPEAN HEART JOURNAL (2009)
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial
Patricia J. M. Best et al.
AMERICAN HEART JOURNAL (2008)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Renal function and outcomes in acute coronary syndrome: impact of clopidogrel
Matyas Keltai et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2007)
分享论文
